Whether this reflects genuine cardiovascular benefit or simply the healing of minor injuries that were limiting exercise capacity remains unclear
If you respond well to GLP-1 stimulation alone, semaglutide gets you significant weight loss at a lower price point
The original paper is in Mandarin and you can access it here (paywall): #Type2Diabetes #DiabetesResearch #Obesity #GLP1 #Semaglutide #Dorzagliatin #MetabolicHealth #HuaMedicine To view or add a comment, sign in A newly published peer-reviewed scientific paper from China adds to the growing body of evidence around the benefits that dorzagliatin (GKA) in combination with the popular semaglutide (GLP-1RA) delivers superior glycemic control, weight reduction, and islet cell function improvement when compared with semaglutide monotherapy in obese patients with Type 2 diabetes mellitus (T2DM), with a comparable safety profile
Personalized Roadmap: Clear plan covering nutrition , movement , sleep , stress , and the least-intensive therapy likely to work
Injury healing protocols should plan reconstitution timing to match usage patterns, avoiding unnecessary degradation from extended reconstituted storage
Always look for third-party lab testing (Certificate of Analysis), vendor transparency, and real peptide content